Masthead

NanoString Blog

Category: Q&A

Masthead
Checkpoint inhibitors

Digital Spatial Profiling Q&A

Q&A with Dr. Aubrey Thompson, Ph.D.: The GeoMx® Digital Spatial Profiler is Turning the Tables on Breast Cancer

E. Aubrey Thompson, Ph.D is a Professor in the Department of Cancer Biology at the Mayo Clinic in Jacksonville, FL. His research focuses on breast cancer and using genomic and…

Laura Tabellini Pierre / April 27, 2020
Blue background showing lab materials

Grants nCounter Panels Q&A

The Innovative Way Metabolic Pathways Panel is Being Used

Liver disease encompasses multiple conditions preventing the liver from functioning. These conditions are often associated with altered metabolic pathways including altered glucose and lipid metabolism. in 2019 NanoString® awarded a…

Laura Tabellini Pierre / March 16, 2020
Colored scan of T lymphocytes and a cancer cell

Oncology Q&A

Q&A with Dr. Lisa Butterfield, PhD: Cancer Vaccines & Adoptive Cell Transfer

Dr. Lisa Butterfield, PhD recently joined the Parker Institute for Cancer Immunotherapy as Vice President focusing on cell therapies while she continues her independent cancer vaccine research as an Adjunct…

NanoString / July 8, 2019
miRNA 3d model

Oncology Q&A

Q&A with Dr. Juliane Nguyen: Exosome Profiling with miRNA and Biotech’s Next Breakthrough

Dr. Juliane Nguyen is a professor in the Department of Pharmaceutical Sciences at the University of Buffalo. Her Therapeutic Biomaterials Laboratory investigates using exosomes and other nanoscale carriers for the…

NanoString / November 27, 2018
Graphic of Medicine

Autoimmunity Q&A

Q&A with Darragh Duffy, Ph.D. – Understanding the Healthy Human Immune Response with the LabEx Milieu Interieur Project

Darragh Duffy, Ph.D., is the Scientific Manager of the LabEx Milieu Interieur project at the Institut Pasteur in Paris, France. This ambitious program started in 2011 with the mission to understand…

NanoString / October 10, 2018
3d model of a neuron

Digital Spatial Profiling Neuroscience Q&A

Q&A with Dr. Stefan Prokop – Alzheimer’s: From the Amyloid Hypothesis to the Cellular Phase and Beyond

Stefan Prokop, MD, is a Neuropathologist and Research Fellow at the University of Pennsylvania School of Medicine. His work is focused on Alzheimer’s Disease (AD) with a specific interest in…

NanoString / October 2, 2018
Tissue analysis

Digital Spatial Profiling Q&A

Q&A with Dr. Nick Reder: New Frontiers in Pathology with Digital Spatial Profiling and Light Sheet Microscopy

Dr. Nick Reder, MD, MPH, currently works at the Department of Pathology at the University of Washington in Seattle. Part of his time is spent in collaboration with mechanical engineers…

NanoString / May 22, 2018
3d model of a neuron

Neuroscience Q&A

Rediscovering Microglia: Dr. Oleg Butovsky Discusses the Untapped Potential of Microglia in Neurodegenerative Diseases

Oleg Butovsky, Ph.D., is an Assistant Professor of Neurology at Harvard Medical School. His laboratory at the Center of Neurologic Diseases in Brigham & Women’s Hospital focuses on the basic…

NanoString / April 19, 2018
Spatial Transcriptomics

Digital Spatial Profiling Q&A

Q&A with Dr. Sergio Rutella: Multi-analyte studies in acute myeloid leukemia

Sergio Rutella, M.D., Ph.D. FRCPath is a Professor of Cancer Immunotherapy at the John van Geest Cancer Research Centre at Nottingham Trent University. His research focuses on acute myeloid leukemia…

Robin Lynn White / December 14, 2017
cancer cell rendering

3D Biology™ Technology Q&A

Q&A with Dr. David Coffey, FHCRC: Multi-analyte studies in multiple myeloma and lymphoma

David Coffey, MD, is a physician scientist with the Fred Hutchinson Cancer Research Center in Seattle, Washington. When he’s not treating patients, he’s in the lab researching blood cancers such…

Robin Lynn White / November 16, 2017
cancer cell rendering

3D Biology™ Technology Q&A

Multi-Analyte Analysis of Lung Cancer FFPE Samples with 3D Biology™ Technology

NanoString sat down with McGarry Houghton, M.D., Associate Member of the Clinical Research and Human Biology Divisions at Fred Hutch Cancer Research Center, to discuss how his lab is using…

Robin Lynn White / June 1, 2017
Checkpoint inhibitors

Digital Spatial Profiling Q&A

Characterizing Severe Autoimmune Toxicities Associated with Checkpoint Inhibitor Therapies

Immune checkpoint inhibitors (ICI) have emerged as powerful tools against cancer but in some cases have caused inflammation of organ systems that contributed to morbidity or mortality in patients. The…

Robin Lynn White / March 31, 2017